CBD of Denver, Inc. (OTC:CBDD) reported a strong fourth quarter on Thursday, with revenues reaching roughly $1.310,000 with a split of approximately $1,134,000 for Luxora and approximately $176,000 for Libra 9.
“Despite a challenging economic environment, the increase in revenue confirms that our strategies are driving growth across both verticals," Axel Reinke, CEO of CBD of Denver, said. "With a current order backlog of approximately $150,000 for the Anti-Slip product line, we are confidently entering the new year.”
The Denver-based company attributes its growth to several factors.
In addition to the partnership ...